RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway

Melanoma originates from the malignant transformation of melanocytes. Compared with other skin cancers, melanoma has a higher fatality rate. The 5-year survival rate of patients with early-stage primary melanoma through surgical resection can reach more than 90%. However, the 5-year survival rate of...

Full description

Bibliographic Details
Main Authors: Jie Xu, Pengfei Shi, Fanwei Xia, Xuan Zhao, Junfan Chen, Rui Geng, Hongjuan Cui, Liqun Yang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/19/12036
_version_ 1797478805372141568
author Jie Xu
Pengfei Shi
Fanwei Xia
Xuan Zhao
Junfan Chen
Rui Geng
Hongjuan Cui
Liqun Yang
author_facet Jie Xu
Pengfei Shi
Fanwei Xia
Xuan Zhao
Junfan Chen
Rui Geng
Hongjuan Cui
Liqun Yang
author_sort Jie Xu
collection DOAJ
description Melanoma originates from the malignant transformation of melanocytes. Compared with other skin cancers, melanoma has a higher fatality rate. The 5-year survival rate of patients with early-stage primary melanoma through surgical resection can reach more than 90%. However, the 5-year survival rate of patients with metastatic melanoma is only 25%. Therefore, accurate assessment of melanoma progression is critical. Previous studies have found that Retinoic Acid Induced 14(RAI14) is critical in tumorigenesis. However, the biological function of RAI14 for the development of melanoma is unclear. In this study, RAI14 is highly expressed in melanoma and correlated with prognosis. The expression of RAI14 can affect the proliferation, migration and invasion of melanoma cells. F-Box Protein 32(FBXO32) is an E3 ubiquitin ligase of c-MYC. We found that RAI14 affects the transcriptional expression of FBXO32 and regulates the stability of c-MYC. These results suggest that RAI14 play an important role in the growth of melanoma and is expected to be a therapeutic target for melanoma.
first_indexed 2024-03-09T21:36:47Z
format Article
id doaj.art-efe4f978a7fd4854999af617278ee821
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T21:36:47Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-efe4f978a7fd4854999af617278ee8212023-11-23T20:43:31ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-10-0123191203610.3390/ijms231912036RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC PathwayJie Xu0Pengfei Shi1Fanwei Xia2Xuan Zhao3Junfan Chen4Rui Geng5Hongjuan Cui6Liqun Yang7State Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400716, ChinaMelanoma originates from the malignant transformation of melanocytes. Compared with other skin cancers, melanoma has a higher fatality rate. The 5-year survival rate of patients with early-stage primary melanoma through surgical resection can reach more than 90%. However, the 5-year survival rate of patients with metastatic melanoma is only 25%. Therefore, accurate assessment of melanoma progression is critical. Previous studies have found that Retinoic Acid Induced 14(RAI14) is critical in tumorigenesis. However, the biological function of RAI14 for the development of melanoma is unclear. In this study, RAI14 is highly expressed in melanoma and correlated with prognosis. The expression of RAI14 can affect the proliferation, migration and invasion of melanoma cells. F-Box Protein 32(FBXO32) is an E3 ubiquitin ligase of c-MYC. We found that RAI14 affects the transcriptional expression of FBXO32 and regulates the stability of c-MYC. These results suggest that RAI14 play an important role in the growth of melanoma and is expected to be a therapeutic target for melanoma.https://www.mdpi.com/1422-0067/23/19/12036RAI14c-MYCubiquitinationmelanomaproliferation
spellingShingle Jie Xu
Pengfei Shi
Fanwei Xia
Xuan Zhao
Junfan Chen
Rui Geng
Hongjuan Cui
Liqun Yang
RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
International Journal of Molecular Sciences
RAI14
c-MYC
ubiquitination
melanoma
proliferation
title RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
title_full RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
title_fullStr RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
title_full_unstemmed RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
title_short RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
title_sort rai14 promotes melanoma progression by regulating the fbxo32 c myc pathway
topic RAI14
c-MYC
ubiquitination
melanoma
proliferation
url https://www.mdpi.com/1422-0067/23/19/12036
work_keys_str_mv AT jiexu rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway
AT pengfeishi rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway
AT fanweixia rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway
AT xuanzhao rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway
AT junfanchen rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway
AT ruigeng rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway
AT hongjuancui rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway
AT liqunyang rai14promotesmelanomaprogressionbyregulatingthefbxo32cmycpathway